Strategic US license agreement between Cambridge Laboratories Limited and Prestwick Pharmaceuticals Inc
Acted for Cambridge Laboratories Limited on its strategic US partnership with Prestwick Pharmaceuticals Inc regarding Cambridge's lead product tetrabenazine in September 2002 and November 2005.